Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 56


Clusterin expression in normal mucosa and colorectal cancer.

Andersen CL, Schepeler T, Thorsen K, Birkenkamp-Demtröder K, Mansilla F, Aaltonen LA, Laurberg S, Ørntoft TF.

Mol Cell Proteomics. 2007 Jun;6(6):1039-48. Epub 2007 Feb 23.


Gene-expression signatures in oncology diagnostics.

Mazumder A, Wang Y.

Pharmacogenomics. 2006 Dec;7(8):1167-73. Review.


Gene expression profiling reveals stromal genes expressed in common between Barrett's esophagus and adenocarcinoma.

Hao Y, Triadafilopoulos G, Sahbaie P, Young HS, Omary MB, Lowe AW.

Gastroenterology. 2006 Sep;131(3):925-33.


Angiogenic profile of soft tissue sarcomas based on analysis of circulating factors and microarray gene expression.

Yoon SS, Segal NH, Park PJ, Detwiller KY, Fernando NT, Ryeom SW, Brennan MF, Singer S.

J Surg Res. 2006 Oct;135(2):282-90.


Deciphering cellular states of innate tumor drug responses.

Graudens E, Boulanger V, Mollard C, Mariage-Samson R, Barlet X, Grémy G, Couillault C, Lajémi M, Piatier-Tonneau D, Zaborski P, Eveno E, Auffray C, Imbeaud S.

Genome Biol. 2006;7(3):R19. Epub 2006 Mar 15.


X chromosomal abnormalities in basal-like human breast cancer.

Richardson AL, Wang ZC, De Nicolo A, Lu X, Brown M, Miron A, Liao X, Iglehart JD, Livingston DM, Ganesan S.

Cancer Cell. 2006 Feb;9(2):121-32.


Bid, a BH3-only multi-functional molecule, is at the cross road of life and death.

Yin XM.

Gene. 2006 Mar 15;369:7-19. Epub 2006 Jan 27. Review.


Clusterin is a secreted marker for a hypoxia-inducible factor-independent function of the von Hippel-Lindau tumor suppressor protein.

Nakamura E, Abreu-e-Lima P, Awakura Y, Inoue T, Kamoto T, Ogawa O, Kotani H, Manabe T, Zhang GJ, Kondo K, Nosé V, Kaelin WG Jr.

Am J Pathol. 2006 Feb;168(2):574-84.


Down-regulation of stem cell genes, including those in a 200-kb gene cluster at 12p13.31, is associated with in vivo differentiation of human male germ cell tumors.

Korkola JE, Houldsworth J, Chadalavada RS, Olshen AB, Dobrzynski D, Reuter VE, Bosl GJ, Chaganti RS.

Cancer Res. 2006 Jan 15;66(2):820-7.


Tumor necrosis factor-alpha-induced protein 3 as a putative regulator of nuclear factor-kappaB-mediated resistance to O6-alkylating agents in human glioblastomas.

Bredel M, Bredel C, Juric D, Duran GE, Yu RX, Harsh GR, Vogel H, Recht LD, Scheck AC, Sikic BI.

J Clin Oncol. 2006 Jan 10;24(2):274-87. Epub 2005 Dec 19.


Analysis of orthologous gene expression between human pulmonary adenocarcinoma and a carcinogen-induced murine model.

Stearman RS, Dwyer-Nield L, Zerbe L, Blaine SA, Chan Z, Bunn PA Jr, Johnson GL, Hirsch FR, Merrick DT, Franklin WA, Baron AE, Keith RL, Nemenoff RA, Malkinson AM, Geraci MW.

Am J Pathol. 2005 Dec;167(6):1763-75.


Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression.

Varambally S, Yu J, Laxman B, Rhodes DR, Mehra R, Tomlins SA, Shah RB, Chandran U, Monzon FA, Becich MJ, Wei JT, Pienta KJ, Ghosh D, Rubin MA, Chinnaiyan AM.

Cancer Cell. 2005 Nov;8(5):393-406.


Novel genes associated with malignant melanoma but not benign melanocytic lesions.

Talantov D, Mazumder A, Yu JX, Briggs T, Jiang Y, Backus J, Atkins D, Wang Y.

Clin Cancer Res. 2005 Oct 15;11(20):7234-42.


Proteomic study reveals that proteins involved in metabolic and detoxification pathways are highly expressed in HER-2/neu-positive breast cancer.

Zhang D, Tai LK, Wong LL, Chiu LL, Sethi SK, Koay ES.

Mol Cell Proteomics. 2005 Nov;4(11):1686-96. Epub 2005 Jul 26.


Differentiation of human embryonal carcinomas in vitro and in vivo reveals expression profiles relevant to normal development.

Skotheim RI, Lind GE, Monni O, Nesland JM, Abeler VM, Fosså SD, Duale N, Brunborg G, Kallioniemi O, Andrews PW, Lothe RA.

Cancer Res. 2005 Jul 1;65(13):5588-98.


Identification of novel candidate oncogenes and tumor suppressors in malignant pleural mesothelioma using large-scale transcriptional profiling.

Gordon GJ, Rockwell GN, Jensen RV, Rheinwald JG, Glickman JN, Aronson JP, Pottorf BJ, Nitz MD, Richards WG, Sugarbaker DJ, Bueno R.

Am J Pathol. 2005 Jun;166(6):1827-40.


Alterations in thigh subcutaneous adipose tissue gene expression in protease inhibitor-based highly active antiretroviral therapy.

Chaparro J, Reeds DN, Wen W, Xueping E, Klein S, Semenkovich CF, Bae KT, Quirk EK, Powderly WG, Yarasheski KE, Li E.

Metabolism. 2005 May;54(5):561-7.


Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiation.

Kimchi ET, Posner MC, Park JO, Darga TE, Kocherginsky M, Karrison T, Hart J, Smith KD, Mezhir JJ, Weichselbaum RR, Khodarev NN.

Cancer Res. 2005 Apr 15;65(8):3146-54.

Items per page

Supplemental Content

Write to the Help Desk